TTK Healthcare Limited (NSE:TTKHLTCARE)
1,052.20
+1.00 (0.10%)
Sep 24, 2026, 12:49 PM IST
TTK Healthcare Revenue
TTK Healthcare had revenue of 2.58B INR in the quarter ending June 30, 2026, with 13.75% growth. This brings the company's revenue in the last twelve months to 8.88B, up 8.34% year-over-year. In the fiscal year ending March 31, 2026, TTK Healthcare had annual revenue of 8.57B with 6.96% growth.
Revenue (ttm)
8.88B
Revenue Growth
+8.34%
P/S Ratio
1.67
Revenue / Employee
6.42M
Employees
1,384
Market Cap
14.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.57B | 557.88M | 6.96% |
| Mar 31, 2025 | 8.01B | 487.00M | 6.47% |
| Mar 31, 2024 | 7.53B | 276.84M | 3.82% |
| Mar 31, 2023 | 7.25B | 1.26B | 21.01% |
| Mar 31, 2022 | 5.99B | 1.23B | 25.88% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Marksans Pharma | 31.72B |
| Pfizer | 25.70B |
| Rubicon Research | 19.36B |
| CORONA Remedies | 14.79B |
| Sanofi Consumer Healthcare India | 9.50B |
| SMS Pharmaceuticals | 8.98B |
| Senores Pharmaceuticals | 6.80B |
| Sai Parenteral's | 5.26B |
TTK Healthcare News
- 2 months ago - Wipro Consumer Care buys TTK’s Good Home, Eva brands for Rs 256 cr - The Times of India